PUBM Q3 Deep Dive: AI-Driven Diversification Offsets Legacy DSP Headwinds

Detailed price information for Pubmatic Inc Cl A (PUBM-Q) from The Globe and Mail including charting and trades.

Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia

(Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the positive outcome of its ...
Le Lézard

Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances

Agenus Inc. today reported quarterly results for the period ended September 30, 2025, and provided a business update. Highlights include government?funded, reimbursed compassionate access (AAC) in ...
Le Lézard

SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine

Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS , a global leader in AI-driven precision medicine, to launch and co-market ...